-
Mum is first UK patient to trial new MS treatment
24 Oct 2025 13:00 GMT
ShareSave
Emily Henders is taking part in a trial of T-cell therapy, which has proved successful in treating blood cancer
A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple …
-
Woman has new MS treatment that doctors say could be 'game-changer'
24 Oct 2025 02:29 GMT
A mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or even stop progression of the disease.
Emily Henders, 37, was given an infusion of her own cells that had been weaponised in the lab …
-
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
22 Oct 2025 19:13 GMT
… due in December.
Transforming How MS Drugs Are Delivered
BNT23001 is an … more patient-friendly approach to MS treatment.
With dosing optimization underway and …
-
Best of the Week: Spectroscopy Mini Tutorials, Single Particle ICP-TOF-MS
24 Oct 2025 22:14 GMT
… Using Single-Particle ICP-TOF-MS
Researchers at Oak Ridge National Laboratory …
-
Arctic air to bring first significant cold snap of season to UK
24 Oct 2025 17:07 GMT
… new 'game-changer' MS treatment
The clocks go back on …
-
Biogen licenses Vanqua Bio's immune disorder drug for up to $1.06 billion
24 Oct 2025 12:50 GMT
… to dwindle for its older multiple sclerosis drugs due to rising competition.
Last …
-
Roche in ongoing discussions with US government over drug pricing, CEO says
23 Oct 2025 19:01 GMT
… drug continues to be its multiple sclerosis drug Ocrevus (ocrelizumab), generating SFr5.2bn …
-
What’s Happening – Oct. 23rd Edition
23 Oct 2025 18:18 GMT
… 709-697-8473.
Music for MS Research — Musical Acts, Silent Auction and … be going directly to support multiple sclerosis research at MUN. Donations at the …
-
‘We’re Not Done’: Roche Plans to Sustain Dealmaking Pace After 89bio
23 Oct 2025 14:41 GMT
… billion ($44.54 billion). The multiple sclerosis drug Ocrevus was Roche’s top …
-
Teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS
24 Oct 2025 00:12 GMT
… PA news agency that current MS treatments require ongoing tablets or injections …